🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT03606083
Active, not recruiting Observational

Registry in Patients With Aorto-iliac or Iliac Aneurysms

NCT03606083 · tracked via the Priya Life Science Germany tracker
Sponsor
Phase
Observational
Started
2018-07-15
Last updated
2025-05-02

Condition(s) studied

Vascular Aneurysm

Investigational drug(s) / intervention(s)

Endovascular repair

Endovascular repair: Endovascular repair of aorto-iliac or iliac aneurysms using an iliac branch device (IBD)

Study summary

The PLIANT II registry is undertaken to examine the real-world outcome after treatment of consecutive patients with uni- or bilateral aorto-iliac or iliac aneurysms using the E-liac Stent Graft System.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 85 years * Patient must have an aorto-iliac or iliac aneurysm * Patient must have a unilateral or bilateral iliac aneurysm * Patient´s anatomy must be suitable for stent graft placement on preoperative angio CT scan * Patient must be available for the appropriate follow-up times for the duration of the study * Patient has been informed of the nature of the study, agrees to its provisions and has signed the informed consent form prior to intervention Exclusion Criteria: * Female of child bearing potential * Patients with ruptured iliac aneurysms * Patients with juxtarenal, pararenal or suprarenal aneurysms * Patients pretreated with Nellix (Endologix) or Altura (Lombard Medical) * Patient is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints * Patient with malignancy needing chemotherapy or radiation * Patients with life expectancy of less than 3 years * Patient minor or under guardianship

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitätsklinikum Köln Cologne North Rhine-Westphalia

More JOTEC GmbH trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03606083 on ClinicalTrials.gov ↗ ← All trials in Germany